PATENT CLAIM ANALYSIS

Application Number: 15903851
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates to novel amino acid sequences of peptides derived from HPV 16 that are able to bind to MHC complexes of class II, and elicit an immune response. The present invention further relates to pharmaceutical products, such as vaccines and T-cells, based on said epitopes.

Claim (Index 13):
A pharmaceutical preparation, comprising at least one of: a nucleic acid encoding the peptide according to  claim 1 ; a host cell comprising a nucleic acid encoding the peptide of  claim 1 , wherein said host cell is an antigen presenting cell and presents the peptide according to  claim 1 ; an activated T cell, wherein said T cell selectively recognizes cells that express an HPV polypeptide comprising a sequence according to SEQ ID NO: 4 or a variant thereof that is at least 80% homologous to SEQ ID NO: 4, wherein said peptide, or one or more parts thereof, has the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-II or -I, and wherein said peptide has from 15 to 50 amino acids; and wherein said preparation further comprises a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.29268
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15104165', '12451983', '15678970', '14453286', '10433936']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.749700022243889
- 35 USC 102 Novelty (BERT): 0.6075755936824442
- Combined Prediction Score: 0.7354875793877446
- Mean Citation Score: 451.469304
- Max Citation Score: 601.5992
- Similarity Product: 449.4271489387512

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test